6 results
IBS-D Pharmacotherapy

Loperamide
Rifaximin
Eluxadoline
Alosetron
Antispasmodics
Tricyclic antidepressants
SSRIs

#IBSD #IBS #Diarrhea #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
IBS-D Pharmacotherapy ... #IBS #Diarrhea ... #Irritable #Bowel ... #pharmacology #table ... #comparison #management
IBS-C Pharmacotherapy

Polyethylene glycol
Lubiprostone
Linaclotide
Plecanatide
Tegaserod
Tenapanor

#IBSC #IBS #Constipation #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
IBS-C Pharmacotherapy ... Tenapanor #IBSC #IBS ... #Constipation #Irritable ... #pharmacology #table ... #comparison #management
Irritable Bowel Syndrome (IBS) - Pathophysiology, Diagnosis and Management Algorithm
Risk factors: Previous acute enteric infection, Female
Irritable Bowel ... Diagnosis and Management ... Algorithm Risk ... acute enteric infection ... #Irritable #Bowel
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... suspension 400 mg PO BID ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Histoplasma Capsulatum Infections ... for 3 days, then BID ... with ARV (see Table ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Clarithromycin 500 mg PO BID ... please refer to Table ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology